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Defective glomerular [3HJIysoPAF metabolism in the autologous phase
of rabbit nephrotoxic nephritis. Glomerular infiltration of blood-derived
mononuclear cells contributes to the glomerular injury in the autologous
phase of nephrotoxic nephritis (NTN). Lys0PAF has recently been
shown to be chemotactic for human monocytes, thus its accumulation
might account for monocyte recruitment. We investigated [3HIIys0PAF
metabolism in isolated glomeruli from normal and NTN rabbits studied
both in the heterologous and in the autologous phases of the disease.
[3H]lysoPAF was converted to [3H}I-O-alkyl-glycerol and [3HJ1-O-
alkyl-2-acyl-GPC by phospholipase C and acyltransferase, respectively,
both in normal and NTN glomeruli. Glomerular metabolism of [3H]lyso-
PAF was normal during the heterologous phase of NTN. By contrast, in
isolated glomeruli from NTN rabbits studied in the autologous phase of
the disease, a significantly lower [3HJlysoPAF degradation occurred
with respect to normal ones. This defective degradation resulted in a
significantly reduced formation of [3H]1-O-alkyl-glycerol. The apparent
Km for enzymatic conversion of [3H]lysoPAF to [3H] 1-0-alkyl-glycerol,
determined at 15 minutes as a function of [3H]lysoPAF concentration,
was doubled in glomeruli from rabbits studied in the autologous phase
of NTN as compared to normal ones, while Vmx values were similar in
the two groups. These results show a defective glomerular lysoPAF
degradation in the autologous phase of NTN, likely due to a decreased
affinity of phospholipase C to lysoPAF. Altered lysoPAF metabolism
results in glomerular accumulation of ZysoPAF in the autologous phase
of NTN, as shown by significantly higher levels of lysoPAF measured
in nephritic glomeruli as compared to normal ones.
Rabbits injected with anti-rabbit glomerular basement mem-
brane (GBM) serum develop a proliferative glomerulonephritis
with glomerular fibrin deposition and progressive deterioration
of renal function [1]. The disease develops in two subsequent
steps: an early (heterologous) phase, occurring within 24 hours
after antibody binding to GBM and characterized by comple-
ment activation, neutrophil infiltration, proteinuria, and fall in
glomerular filtration rate (GFR); and a late (autologous) phase,
which ensues at days 7 to 14 after the injection of the antiserum,
is dependent on a macrophage/monocyte infiltration and mani-
fests with proteinuria, extracapillary cellular proliferation and
renal failure [2—6]. Previous studies in rabbits with nephrotoxic
nephritis (NTN) have shown that macrophage depletion abro-
gates proteinuria and protects from renal failure [5—8], indicat-
ing that the recruitment of macrophages in the glomeruli is
responsible for the evolution of renal injury in this model.
However, the signal(s) for macrophages to accumulate at the
glomerular level in such circumstances is still a matter of
speculation.
Recent studies on platelet activating factor (PAF), a potent
mediator of inflammation released after an immunological chal-
lenge from inflammatory cells and platelets [9, 10], may be
relevant to this issue. In cell systems PAF is formed by the
action of phospholipase A2 that deacylates 1 -O-alkyl-2-acyl-sn-
glycero-3-phosphocholine (alkyl-acyl-GPC) to form 1-0-alkyl-
2-lyso-GPC (lysoPAF) which is converted to PAP [11, 12]. PAF
may subsequently be inactivated to l-O-alkyl-acyl-GPC via
lysoPAF [13, 14]. Thus lysoPAF is an obligatory intermediate
for both biosynthesis and inactivation of PAF. A second
metabolic pathway for PAF and lysoPAF has recently been
shown, which implies the cleavage of the phosphocholine group
by a lysosomal phospholipase C [15, 16] to form the corre-
sponding I -0-alkyl-glycerols.
Lianos and Zanglis have recently observed that PAF glomer-
ular levels increase in rats with NTN in both phases of the
disease [17]. These investigators also provided indirect evi-
dence that glomerular lysoPAF is increased in the autologous
phase of NTN [17].
Recently it has been recognized that lysoPAF has its own
biological activity consisting in a chemotactic effect for human
monocytes in a dose-dependent fashion, a property that may
not be shared by PAF [18]. It is possible that lysoPAF accu-
mulates into the glomerulus during the autologous phase of
NTN and functions as a stimulus for macrophage/monocyte
recruitment within the glomeruli.
The current study was therefore designed with the following
aims: (1) to clarify the glomerular metabolism of lysoPAF in the
rabbit; (2) to evaluate whether the autologous phase of NTN
may be associated with changes in glomerular lysoPAF metab-
olism, and (3) to evaluate whether lysoPAF accumulates in
nephritic glomeruli.
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Materials
[3HIPAF ([1' ,2'-3HJ 1 -0-hexadecyl-2-acetyl-GPC; 56.7 Ci!
mmol), [3H]lysoPAF ([1' ,2'-3H] I -O-alkyl-2-lyso-GPC; 52.0 Cit
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mmol), [3HJ 1 -O-alkyl-2-acyl-GPC ([1' ,2'-3H1 I -O-alkyl-2-arachi-
donyl-GPC; 40 Ci/mmol) were purchased from New England
Nuclear (Boston, Massachusetts, USA), [3HIIysoPAF and
[3H1 I -O-alkyl-2-acyl-GPC were a mixture of isomers with hexa-
decyl, octadecyl and tetradecyl alkyl moiety. As indicated by
New England Nuclear, the distribution of radiolabel among
various alkyiglyceryl-ethers in [3H]lysoPAF is: hexadecyl-
68%; octadecyl- 10%; tetradecyl- 6%; others 16%. Unlabeled
1-0-hexadecyl-glycerol was from Fluka Chemie (Buchs, Swit-
zerland). Unlabeled 1-O-hexadecyl-2-lyso-GPC (lysoPAF) was
from Bachem Feinchemikalien (Bubendorf, Switzerland). 1-0-
alkyl-2,3-diacetyl-glycerol was prepared from 1-0-hexadecyl-
glycerol by treatment with acetic anhydride as previously
described [19]. 1-stearoyl-2-arachidonyl-glycerol was synthe-
sized by hydrolysis with phospholipase C (from Bacillus cereus
type II, Boheringer Mannheim, Germany) of L-s-phosphatidyl-
choline-/3-arachidonyl-y-stearoyl (Sigma Chemical Co., St.
Louis, Missouri, USA).
HPLC and analytical grade solvents, sodium hydroxide
(NaOH) and thin layer chromatography plates, precoated with
Silica Gel 60, layer thickness 0.25 mm, were purchased from
Merck (Darmstadt, Germany). Silicic acid (100 to 200 mesh)
was obtained from Bio-Rad Laboratories (Richmond, Califor-
nia, USA). Bovine serum albumin (BSA fraction V), Dragen-
dorif's reagent, pyridine, 4-N-dimethylamino-pyridine and ace-
tic anhydride were from Sigma.
Experimental design
NTN was induced in male New Zealand white rabbits
(Charles River S.p.A., Calco, Italy) weighing 2 to 2.5 kg, by the
intravenous injection of 1.5 mI/kg body weight of ram-anti-
rabbit GBM serum as previously described [201. The ram
antiserum was given in three administrations at intervals of one
hour between the first and the second injection and 40 minutes
between the second and the third one. Nephrotoxicity of ram
antiserum was assessed by the development of proteinuria, the
impairment of renal function and by morphological evaluation
of glomeruli with light microscopy, immunofluorescence and
electron microscopy as previously described [20].
Three groups of animals were used for the study: (1) normal
rabbits (N = 18), (2) rabbits with NTN (N = 8) sacrificed 24
hours following anti-GBM antiserum administration (heterolo-
gous phase), (3) rabbits with NTN (N 18) sacrificed 14 days
following anti-GBM antiserum administration (autologous
phase).
Rabbits with NTN developed heavy proteinuria (heterolo-
gous phase: 6185 3260 mg protein/day, autologous phase: 753
296 mg protein/day as determined by Coomassie blue G,
dye-binding assay) [21]. Renal function, measured as creatinine
clearance [20], was sharply impaired both 24 hours and 14 days
after the antiserum injection in respect to basal values (24
hours: 1.2 0.6 vs. 3.4 0.3 mI/mm/kg body wt, P < 0.01; 14
days: 0.9 0.4 vs. 3.2 0.5 mI/mm/kg body wt, P < 0.01).
Histological examination of kidney specimens from rabbits
sacrificed 24 hours after the antiserum injection revealed gb-
merular polymorphonuclear cell infiltration and deposition of
proteinaceous material in Bowman's space [20]. In kidney
specimens from animals sacrificed during the autologous phase
of NTN, glomerular infiltrate mainly consisting of mononuclear
cells, intra- and extra-capillary fibrin deposition and crescent
formation were observed [20].
Isolation of glomeruli
Rabbits were anesthetized by intravenous injection of
penthobarbital-sodium. After obtaining specimens for histolog-
ical examination, kidneys were perfused with saline until they
became completely blanched to remove blood-born cells from
the glomeruli, then were quickly removed and placed in ice-cold
Krebs Ringer phosphate buffer (KRB, 120 mM NaCI, 4.8 mM
KCI, 1.2 mivi MgSO4 and 15.6 m phosphate buffer, pH 7.4).
Glomeruli were isolated by differential sieving using a technique
previously described [221 which provides about 90% pure
glomerular preparation for both normal and NTN kidneys.
LysoPAF degradation in normal and NTN glomeruli
To evaluate [3HJlysoPAF metabolism, isolated glomeruli
from normal (N 4) or nephritic rabbits (heterologous phase, N
4; autologous phase, N = 4) were centrifuged at 150 x g for
five minutes; thereafter the pellet was resuspended in KRB
supplemented with 2.5 m CaCl2 and 0.25% BSA. Aliquots of
glomerular suspensions from single animals (2 ml, about 2 mg
protein each) were transferred to polypropylene tubes contain-
ing [3H]lysoPAF (1.5 pCi, about 28.8 pmol, in ethanol) that had
been previously dried under a nitrogen stream. Samples were
incubated in duplicate for 150 minutes at 37°C under constant
shaking.
In additional experiments isolated glomeruli from normal (N
= 8) or NTN rabbits (autologous phase, N = 8) were pooled. To
assess the time course of lysoPAF metabolism aliquots of the
glomerular suspensions (about I mg protein) from normal or
NTN rabbits were incubated with [3HIIysoPAF (28.8 pmol) for
various time periods (5 to 150 mm). To evaluate the apparent
Km and of the enzymatic degradation of [3H]lysoPAF to
[3H]1-0-alkyl-glyccrol, glomeruli (about 0.5 mg protein) from
normal and NTN rabbits were incubated at 37°C for 15 minutes
with increasing amounts (range 0.5 to 25 mol/1iter) of lysoPAF
containing 1 pCi of [3H]lysoPAF. Each incubation was per-
formed in triplicate.
All incubations were stopped by adding 4 ml acidified meth-
anol, pH 3. After gentle mixing for 30 minutes, samples were
centrifuged at 2000 x g for 15 minutes to precipitate denatured
glomerular proteins, then the pellet was resuspended in 2 ml
acidified methanol, vortexed and centrifuged once again. Su-
pernatants were extracted according to the Bligh and Dyer
procedure [23], and pellets were dissolved in NaOH IN for
protein determination 1241. The chloroform-rich phase of ex-
tracts was dried under nitrogen and purified according to the
method of Pinckard, Farr and Hanahan [25] with the following
modifications: samples were resuspended in 1 ml of chloroform/
methanol 9:1 (vol/vol) and loaded on a column packed with 0.5
g of silicic acid (Bio-Rad Laboratories, 100 to 200 mesh)
activated overnight at 100°C. The column was eluted sequen-
tially with 15 ml of chloroform, 15 ml of acetone, 15 ml of
acetone/methanol (1:1 vol/vol), 30 ml of chloroform/methanol
(1:4 vol/vol). The third and the fourth fractions of the column,
containing phospholipid metabolites, were combined and dried.
An aliquot of each sample was dissolved in 200 d of chloro-
form/methanol 2:1 (vol/vol) and analyzed by HPLC. Samples
were chromatographed by isocratic elution on a Perkin Elmer
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Silica A Column (2.6 x 250 mm; Perkin-Elmer, Norwalk,
Connecticut, USA), connected to a Beckman model 342 Gra-
dient Liquid Chromatograph (Beckman Instruments Inc., Ber-
keley, California, USA). The eluent was acetonitrile/methanol/
85% phosphoric acid 130:5:1.5 (vol/vol/vol) as described by
Chen and Kou [26]. The flow rate was 1.5 mI/mm and 0.75 ml
fractions were collected and assayed for radioactivity by scin-
tillation counting. Labeled products were separated and identi-
fied on the basis of the retention time of the corresponding [3H]
standards. Portions of the extracts as well as of the various
fractions of the silicic acid column were used for calculation of
recoveries which were above 90% and 85% for the extraction
and the silicic acid column, respectively.
The chloroform fraction of the silicic acid column, containing
neutral lipid metabolites, was dried, redissolved in chloroform!
methanol 9:1 (vol/vol) and spotted on a Silica-Gel thin-layer
plate. Ten micrograms of unlabeled 1-0-alkyl-glycerol were
applied closed to the samples. The thin-layer plates were
developed in a solvent system of chloroform/methanol 98:3
(vol/vol) (solvent system I). Unlabeled lipid standard was
sprayed with a solution of 0.025% of Rhodamine 6G (Merck) in
ethanol and visualized under ultraviolet light. The plates were
scraped at 1 cm intervals and scraping was placed into plastic
vials containing 10 ml of scintillation mixture (Instagel H,
Packard Instruments, Downers Grove, Illinois, USA) for deter-
minations of radioactivity using a Beckman LS 1701 liquid
scintillation counter (Beckman Instruments).
Subcellular fractionation
In additional experiments, subcellular fractions (membranes,
microsomes, cytosol) were prepared from isolated glomeruli
from two normal rabbits. Glomeruli were homogenized four
times for 30 seconds with an Ultra-Turrax homogenizer (Jankle
and Kunkel GMBH and Co., KG, IKA-WERK Staufen, Ger-
many) in 10 ml of KRB, and centrifuged at 500 x g for two
minutes in order to eliminate glomerular debris. The superna-
tant was centrifuged at 10,000 x g for 15 minutes and the pellet
(including plasma membranes, lysosomes and mithocondria)
saved for further purification. The 10,000 x g supernatant was
centrifuged at 100,000 x g for 60 minutes to prepare mi-
crosomes (100,000 x g pellet) and cytosol (100,000 X g super-
natant). The 10,000 x g pellet was resuspended in KRB,
homogenized twice for 30 seconds and then recentrifuged at
100,000 x g for 60 minutes to get rid of any trapped cytosol.
Homogenization and all subsequent procedures were carried
out at 0 to 4°C. Membranes, microsomes and cytosol were
divided into three aliquots and incubated for 15 minutes at 37°C
in 2 ml of KRB supplemented with 0.25% BSA and 2.5 m'vi
CaCl2 in the presence of 5 nmol (2.5 M) [3H]lysoPAF. At the
end of the incubation period samples were extracted and
processed as described above.
LysoPAF degradation in lung homogenate
To evaluate whether possible alterations of lysoPAF metab-
olism in NTN rabbits were confined to the kidney, the kinetic
parameters of [3HJIys0PAF degradation to [3H] 1 -0-alkyl-glyc-
erol in the lung homogenate were also evaluated. Lungs from
normal (N = 3) and NTN rabbits (autologous phase, N = 3)
were removed, finely minced with a razor blade and homoge-
nized in 20 ml of ice-cold KRB using an Ultra-Turrax homog-
enizer (3 x 30 seconds). The homogenate was centrifuged at
25,000 x g for 10 minutes at 4°C, thereafter the pellet was
washed with 20 ml of ice-cold KRB and centrifuged once again.
The pellet was resuspended in KRB supplemented with 0.25%
BSA and 2.5 m CaCI2 and aliquots (about 2 mg protein each)
were incubated at 37°C for 15 minutes with increasing amounts
(range 0.5 to 25 rnol/liter) of lysoPAF containing 1 Ci of
[3H]lysoPAF. Each incubation was performed in duplicate.
Samples were extracted and analyzed as described above.
Identification of products of[3H]lysoPAF metabolism
The labeled metabolite comigrating with 1-0-alkyl-glycerol
on TLC was extracted with dichloromethane. A portion of the
extract was subjected to alkaline hydrolysis (NaOH 2 N) for 30
minutes at room temperature. The product was analyzed by
TLC (solvent system I) and RF values were compared with
those of authentic 1-0-alkyl-glycerol. Another portion was
subjected to acetylation according to the procedure described
by Benfenati et al [19]. In brief, the extract was dissolved in 200
p1 of acetic anhydride and heated at 80°C for three hours. The
product was analyzed by TLC using a solvent system of
chloroformlmethanol/glacial acetic acid 96:4:1 (vol/vol) (solvent
system II) and RF values were compared with those of synthetic
l-O-alkyl-2,3-diacetyl glycerol. Labeled phospholipid metabo-
lites coeluting with standard [3H} l-O-alkyl-2-acyl-GPC and
[3H]lysoPAF in HPLC were also analyzed by TLC using a
solvent system of chloroform/methanol/water 65:35:4 (vol/vol)
(solvent system III). Authentic standards of L-a-phosphatidyl-
choline-f3-arachidonyl-y-stearoyl and lysoPAF were co-chro-
matographed and visualized by Dragendorif's reagent. A por-
tion of the labeled compound coeluting with standard [3H] 1-0-
alkyl-2-acyl-GPC was subjected to brief alkaline hydrolysis
(NaOH 2 N) for 30 minutes at room temperature. The product
was analyzed by TLC (solvent system III) and RF values were
compared with those of lysoPAF and L-a-phosphatidylcholine-
f3-arachidonyl-y-stearoyl standard. Another portion was sub-
jected to phospholipase C treatment (500 U/ml at 37°C for 90
mm) [27]. The product was analyzed by TLC (solvent system I)
and RF values were compared with those of standard 1-0-
stearoyl-2-arachidonyl-glycerol.
LysoPAF levels in normal and NTN glomeruli
Glomerular lysoPAF content was indirectly evaluated by
radioimmunoassay (RIA) after its chemical conversion to PAF.
Isolated glomeruli from normal (N = 4) or nephritic rabbits
(heterologous phase, N = 4; autologous phase, N = 6) were
resuspended in ice-cold KRB. Glomerular suspensions from
each animal were divided into two aliquots which were spiked
with approximately 5,000 cpm of [3H]PAF standard in order to
calculate recoveries. Lipids were subsequently extracted with
acidified methanol followed by the Bligh and Dyer procedure as
described above. Both isolation of glomeruli and lipid extrac-
tion were performed at 0°C to avoid degradation of glomerular
phospholipids. One of the two aliquots of each glomerular lipid
extract was subsequently dissolved in 300 jsl of chloroform!
pyridine 3:1 (vollvol) and acetylated in the presence of acetic
anhydride, 30 p1, and of 4-N-dimethylamino-pyridine, 2 mg, for
18 hours at room temperature as described [17]. This procedure
completely acetylates glomerular lysoPAF to PAF. Acetylated
and not acetylated glomerular lipid extracts were subsequently
xI
0,
0a
purified by a silicic acid column as described above. Purified
samples were assessed for PAF content by a specific radioim-
munoassay as previously described [281. Glomerular lysoPAF
levels were calculated by subtracting data from not-acetylated
aliquots (which reflected PAF levels) to total glomerular PAF
(PAF plus lysoPAF) measured in acetylated samples. Results
were expressed as pmol/mg glomerular protein.
Statistical analysis
All results are expressed as mean SD. Results were
analyzed by the Kruskall-Wallis test and Ryan's procedure or
by one-way or two-way analysis of variance with Tukey-
Cicchetti test for multiple comparisons, as appropriate. Proba-
bility values <0.05 were considered to be statistically signifi-
cant. Linear regression analysis was performed to evaluate the
"apparent" Km and ''Tmax of the enzymatic degradation of
[3H]lysoPAF to [3H11-O-alkyl-glycerol in normal and NTN
tissues. Ninety-five percent Confidence Interval of the differ-
ence between slopes was calculated.
Results
Figure 1 shows a representative fractionation of radiolabeled
phospholipid extract from normal glomeruli incubated for 150
minutes with [3HJ1ysoPAF. HPLC analysis yielded a radiochro-
matogram containing two major peaks coeluting with authentic
[3H111-O-alkyl-2-acyl-GPC and [3H]lysoPAF, respectively. The
TLC analysis of neutral lipid metabolites (Fig. 2) showed a
single band with RF = 0,23 which comigrated with authentic
1-0-alkyl-glycerol. After 150 minutes incubation, the percent-
age of radioactivity comigrating with [3H] 1-0-alkyl-glycerol and
['HIl-O-alkyl-2-acyl-GPC was 59.7 9.1 and 15.7 4.9%,
respectively (N 4). These data suggest that in isolated
glomeruli from normal rabbits [3H]lysoPAF metabolism occurs
by the action of either a phospholipase C or an acyltransferase.
An alternative mechanism to account for the observed for-
mation of 1 -0-alkyl-glycerol from lysoPAF would involve the
stepwise actions of microsomal lysophospholipase D and phos-
1 -0-hexadecyl-glycerol
I I I I
Distance from the origin, cm
Fig. 2. TLC of neutral lipid metabolites from isolated normal rabbit
glomeruli incubated with [3HJIysoPAF (28,8 pmol) for 150 minutes at
37°C. Solvent system, chloroform: methanol 98:3 (vol/vol).
phatidate phosphohydrolase [29]. To investigate such a possi-
bility, additional experiments were performed, where subcellu-
lar fractions from normal glomeruli were incubated with
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[3H}1 -O-alkyl-2-acyl-GPC
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Fig. 1. HPLC radiochromatogram of normal
glomeruli phospholipid extract from 150
minutes of incubation at 37°C with
[3HJlysoPAF (28.8 pmol). The glomerular
extract was purified and analyzed by straight
0 2 4 6 8 10 12 14 16 phase HPLC as described in Methods. Solvent
system, acetonitrile: methanol: phosphoric
acid (130:5:1.5 vol/vol/vol), flow rate 1.5 ml!
minutes.Retention time, minutes
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Membranes Microsomes Cytosol
%Of total activity 63.4 6.06 23.3 2.07 13.3 1.5
[3H]lysoPAF and then extracted and purified for [3H1 1-0-alkyl-
glycerol determination. As shown in Table 1, 63% of total
enzymatic activity, expressed as ng alkyl-glycerol/minute/mg
glomerular protein, were located in the membrane fraction,
whereas little activity was found both in the microsomes and in
the cytosol.
We further investigated lysoPAF metabolism in isolated
glomeruli from NTN rabbits studied both in the heterologous
and in the autologous phase of the disease. After 150 minutes of
incubation, the HPLC and TLC profiles of [3H]lysoPAF metab-
olites in NTN glomeruli were qualitatively similar to control
ones. However, in isolated glomeruli from animals sacrificed
during the autologous phase of NTN, formation of [3H]l-O-
alkyl-glycerol was significantly reduced than in normal glomer-
uli and in glomeruli from animals sacrificed during the heterol-
ogous phase of the disease (P < 0.05 vs. normal and NTN 24
hours). On the contrary, the formation of [3H] l-O-alkyl-2-acyl-
GPC was similar in normal and NTN glomeruli. Results,
expressed as pmollmg glomerular protein, are depicted in
Figure 3.
The time course of [3HJIysoPAF degradation by isolated
glomeruli from both normal and NTN rabbits studied in the
autologous phase of the disease is illustrated in Figure 4. In
isolated glomeruli from normal rabbits E3H]lysoPAF was de-
graded greatly and time-dependently until 150 minute incuba-
tion. The decrease of [3H]lysoPAF content was accompanied
by an increase in either [3H]l-O-alkyl-glycerol or [3H]1-O-alkyl-
2-acyl-GPC levels. [3H] 1 -0-alkyl-glycerol was the major metab-
olite at each incubation time considered. When [3H]lysoPAF
was incubated with isolated glomeruli from NTN rabbits, its
metabolism was reduced as compared to normal glomeruli.
Results, expressed as residual pmol [3HIlysoPAF, showed a
significant difference (P < 0.05) between the two groups at
incubation time of 30 to 150 minutes (Fig. 4). The defective
degradation of [3HJlysoPAF in NTN glomeruli resulted in a
significantly (P < 0.01) reduced formation of [3H]l-O-alkyl-
glycerol at incubation time of 15 to 150 minutes. On the
contrary, the levels of the second metabolite [3Hj l-O-alkyl-2-
acyl-GPC were comparable in normal and NTN glomeruli.
Conversion of [3H]lysoPAF to [3H11-O-alkyl-glycerol in iso-
lated glomeruli from normal and NTN rabbits (autologous
phase) was further studied as a function of the substrate
concentration. The "apparent" Km and Vmax values for
[3H]lysoPAF conversion to [3H11-O-alkyl-glycerol, determined
in 15-minute incubation experiments, were deduced from Line-
weaver-Burk plots of 1/V versus l/[lysoPAF] (Fig. 5). The
maximum velocity for hydrolysis of [3H]lysoPAF was similar in
NTN and in normal glomeruli (0.17 vs. 0.16 nmollmin/mg
glomerular protein), whereas "apparent" Km of the enzymatic
[3H]alkyl-glycerol [3H]acyIPAF
Fig. 3. [3HJIys0PAF metabolism in isolated glomeruli from normal (•)
and NTN (heterologous phase, NTN 24 hours, autologous phase,
NTN 14 days, LI) rabbits. Isolated glomeruli from single animals (about
2 mg protein) were incubated with [3H}lysoPAF (28.8 prnol) at 37°C for
150 minutes. Each incubation was performed in duplicate. Samples
were purified and analyzed as described in Methods. Results are
expressed as pmol/mgglomerular protein. Values are means so (N =
4). * P < 0.05 vs. normal and NTN (24 hours). [3F1]ayiPAF.
[3H]alkyl-2-acyl-GPC.
reaction was doubled in NTN glomeruli as compared to normal
ones (18.13 vs. 8.66 SM). The 95% Confidence Interval of the
difference between slopes of the Lineweaver-Burk plots of
normal and NTN glomeruli ranged from —55.5 to —36.3,
indicating that the two slopes were significantly different. By
contrast, the "apparent" Vmax and Km for [3HjlysoPAF con-
version to [3H]1-O-alkyl-glycerol in lung homogenate from
NTN rabbits (autologous phase) were quite comparable to
normals (Vmax: normals 0.057 0.009, NTN 0.06 0.02
nmol/min/mg protein; Km: normals 19.12 10.6, NTN 23.20
4.71 /LM, N = 3).
To evaluate whether lysoPAF accumulates within the kidney
in the autologous phase of NTN, glomerular lysoPAF levels
were evaluated in normal and nephritic rabbits. As shown in
Figure 6, significantly higher lysoPAF c°ntent was measured in
glomeruli from rabbits sacrificed during the autologous puase of
NTN in comparison to normal glomeruli (255 119.7 vs. 113
11.5 pmol/mg protein, P < 0.05). By contrast, glomerular
lysoPAF in NTN rabbits studied in the heterologous phase of
the disease was comparable to normal animals (135 26.5
pmol/mg protein).
The identification experiments performed on products ob-
tained from incubation of glomeruli and lung homogenate with
[3H]lysoPAF revealed the following: when the labeled product
comigrating with 1-0-alkyl-glycerol was subjected to acetyla-
tion, it comigrated with 1-O-alkyl-2,3-diacetyl glycerol standard
in solvent system II, indicating that the polar head group of
[3H}lysoPAF had been cleaved. The same compound was
resistant to alkaline hydrolysis; this was suggestive of the
presence of an ether bond in position sn-i. When the compound
comigrating with [3H] 1-O-alkyl-2-acyl-GPC standard was sub-
jected to mild alkaline hydrolysis, it was quantitatively con-
verted to a product comigrating with lysoPAF on TLC. This
Table 1. Subcellular localization of 13H] 1-0-alkyl-glycerol synthesis
in glomeruli from normal rabbits
Subcellular fractions from normal glomeruli were prepared by se-
quential centrifugation and incubated with [3H]lysoPAF for 15 mm at
37°C. Lipids were extracted and analyzed by TLC. Results are ex-
pressed as % of total enzymatic activity. Values are means SD (N =
3).
C
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Fig. 4. Time course of f3HJlysoPAF metabolism by isolated glomneruli
from normal (•) and NTN (14 days, 0) rabbits. Glomeruli (about 1
mg/protein) were incubated with [3H]lysoPAF (28.8 pmol) at 37°C for
various time points (range: 5 to 150 mm, N = 3 for each point).
Glomerular suspensions were subsequently extracted and analyzed as
described in Methods. Results are expressed as residual pmol for
[3H]lysoPAF (A) and as pmol/mg glomerular protein for metabolic
products (B and C). Values are means SD. * P<0.05, ** P <0.01 vs.
normal.
was indicative that the compound was esterified in position sn-2
and had an ether bond in position sn-i. Finally, when the same
product was subjected to phospholipase C treatment it comi-
grated with i-stearoyl-2-arachidonyl-glycerol standard in sol-
vent system I.
Discussion
With the present study we have documented that normal
rabbit glotneruli rapidly and extensively metabolize lysoPAF to
1-0-alkyl-glycerol and to 1-O-alkyl-2-acyl-GPC.
Previous studies in rabbit platelets [30] and in rabbit alveolar
macrophages [311 have shown that lysoPAF is converted to
i-O-alkyl-2-acyl-GPC by the enzyme acyltransferase. More-
over, conversion of lysoPAF and PAF to 1-0-alkyl-glycerol by
specific Iysosomai phospholipase C has been recently docu-
mented in isolated cells [16] and in tissues [15]. The conversion
of lysoPAF to 1-0-alkyl-glycerol has been also attributed to the
stepwise actions of microsomal lysophospholipase D and phos-
phatidate phosphohydrolase [29]. In our experiments with
subcellular fractions we found that as much as 63% of the total
1-0-alkyl-glycerol from rabbit glomeruli is accounted for by the
membrane fraction whereas 23% was recovered in the micro-
somal fraction. These data would indicate that in rabbit glomer-
uli lysoPAF conversion to 1-0-alkyl-glycerol occurs mainly via
a membrane linked phospholipase C and secondary via the
actions of lysophospholipase D and phosphatidate phosphohy-
drolase.
Here we have also documented that lysoPAF metabolism is
markedly reduced in isolated glomeruli from NTN rabbits
studied during the autologous phase of the disease, as compared
to normal rabbit glomeruli. The reduced lysoPAF degradation
was mostly due to its reduced conversion to 1-0-alkyl-glycerol.
This abnormality is likely a consequence of a defective phos-
pholipase C activity, which mediates the main metabolic path-
way of lysoPAF in rabbit glomeruli. By contrast glomerular
acyltransferase activity was comparable in NTN and normal
glomeruli as indicated by findings of similar amount of [H]l-
O-alkyl-2-acyl-GPC after exposure to radiolabeled lysoPAF. At
variance with the autologous phase, glomerular lysoPAF me-
tabolism was normal in the heterologous phase of rabbit NTN.
It is possible that infiltrating leukocytes contribute to lysoPAF
degradation within the glomerulus in the heterologous phase of
NTN thus leading to a normal "net" lysoPAF metabolism.
To clarify whether the defective phospholipase C activity in
nephritic glomeruli was the consequence of a reduced affinity of
the enzyme for the substrate or rather due to a lower absolute
amount of the enzyme, we calculated the Km and Vmax of
[3HJlysoPAF degradation to 1-0-alkyl-glycerol. Finding of sim-
ilar Vm,,x in normal and nephritic glomeruli but increased Km in
the latter, suggests that the abnormality might be due to a
reduced affinity of phospholipase C for lysoPAF. It is possible
that the affinity of phospholipase C for lysoPAF is reduced by
virtue of an endogenous inhibitor which may bind to the active
site of the enzyme. Identical Vmax of the enzymatic degradation
of lysoPAF but increased Km in NTN glomeruli would indeed
be consistent with a competitive inhibition. Alternatively, in-
flammatory cells present in NTN glomeruli could act as "lyso-
PAF-sucklers" and make lysoPAF less available to phospho-
lipase C.
Vmax and Km of [3HJ1ys0PAF conversion to [3H]l-O-alkyl-
glycerol was comparable in lung homogenate from normal and
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Fig. 5. Double-reciprocal plot of [3 HJalkyl-
glycerol formation by isolated glomeruli
from normal (•) and NTN (14 days, 0)
rabbits as a function of concentration of
[3H]lysoPAF. Isolated glomeruli (about 0.5
mg protein) were incubated with different
concentrations of [3H]lysoPAF (range 0.5 to
25 mol/1iter, N = 3 for each point) for 152.0 minutes and subsequently purified and
analyzed as described in Methods. Values
are means SD.
nephritic rabbits, suggesting that the altered lysoPAF metabo-
lism in the autologous phase of NTN was confined to the
kidney.
Several cell types in the glomerulus might account for the
altered metabolism of lysoPAF in the autologous phase of
NTN, Mesangial cells [32, 331 as well as vascular endothelial
cells [34] are capable of degrading lysoPAF. Furthermore,
macrophages, which accumulate in the nephritic glomeruli, can
convert lysoPAF to 1-O-alkyl-2-acyl-GPC [31]. However, fail-
ure to find increased formation of [3H]l-O-alkyl-2-acyl-GPC in
NTN glomeruli makes unlikely the possibility that macrophages
play a crucial role in the glomerular metabolism of lysoPAF in
the autologous phase of rabbit NTN.
Defective glomerular lysoPAF metabolism in the autologous
phase of NTN would result in a local accumulation of lysoPAF
in the glomerulus. The possibility that lysoPAF is accumulating
in glomeruli of NTN animals is supported by our finding that
lysoPAF levels, measured as PAF after chemical acetylation of
glomerular extracts, were increased in rabbits with NTN stud-
ied in the autologous phase of the disease. These data are in
agreement with those previously reported by Lianos and Zan-
gus [17] in nephritic rats. Efforts in finding the possible media-
tor(s) of the glomerular macrophage accumulation in NTN are
of great relevance since the degree of macrophage infiltration
may determine the subsequent evolution of the disease to renal
failure [5, 6, 8]. LysoPAF, unlike PAF, is a potent chemotactic
agent for human monocytes/macrophages as shown in a recent
study by Quinn, Parthasarathy and Steinberg [18]. Actually,
these investigators found that lysoPAF exerts a dose-dependent
chemotactic activity to human monocytes while PAF was
inactive. Thus, glomerular lysoPAF accumulation during the
autologous phase of rabbit NTN may be a signal for macro-
phages to migrate within the glomerulus. This possibility is
strengthened by finding that in the heterologous phase of NTN,
which is associated with normal glomerular lysoPAF metabo-
lism, macrophage accumulation does not occur [35].
In conclusion, our present findings indicate that (a) normal
rabbit glomeruli metabolize lysoPAF to 1-0-alkyl-glycerol and
to 1 -O-alkyl-2-acyl-GPC that account respectively for 60% and
16% of lysoPAF metabolism; (b) the glomerular conversion of
lysoPAF to 1-0-alkyl-glycerol is reduced in the autologous
phase of rabbit NTN resulting in a less efficient lysoPAF
degradation; (c) such a defect in lysoPAF degradation is likely
the consequence of a lower affinity of the enzyme phospho-
lipase C for lysoPAF; and (d) reduced lysoPAF degradation is
associated to accumulation of lysoPAF within the nephritic
glomerulus.
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Fig. 6. LysoPAF content in isolated glomeruli from normal (N = 4)
and NTN (heterologous phase: NTN 24 hours, N = 4; autologous
phase: NTN 14 days, N = 6) rabbits. Results are expressed as pmol/mg
glomerular protein. Values are means SD. * P < 0.05 vs. normal.
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Further studies are needed to identify the mechanism(s) of
the reduced phospholipase C activity in NTN glomeruli and to
evaluate whether such a defect is the signal for macrophage
accumulation during the autologous phase of NTN.
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